FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210383784> ?p ?o ?g. }

• W4210383784 endingPage "181" @default.
• W4210383784 startingPage "175" @default.
• W4210383784 abstract "The N-glycosylation of proteins is a typical post-translational modification. Compared with other monoclonal antibodies, N-glycosylation modification in cetuximab is more complicated. Because cetuximab contains two N-glycosylation sites, one is located on the antigen-binding fragment (Fab) and the other is on the crystallizable fragment (Fc) of the heavy chain (HC). Among the two, the glycosylation of the Fab segment is more complicated. As this segment is located in the hypervariable region (VH), it may affect the affinity of the antibody antigen and cause other issues. Therefore, it is necessary to study glycosylation modification at this site. This modification is particularly challenging, necessitating the development of specific glycan cutting technology and a stable glycan ratio analysis method. In this study, cetuximab expressed in Chinese hamster ovary (CHO) cell was used as the experimental research object. Based on the digestion with endo-β-N-acetylglucosaminidase F2 (Endo F2), an experimental method was developed that can quickly release Fab glycans. Qualitative and glycan ratio analyses were carried out by ultra performance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS). The test was divided into two steps: in the first step, a non-denaturing (native state) glycosidase excision test was performed on the CHO-cetuximab drug substance. The drug substance was diluted to 1.0 mg/mL by adding ultrapure water, following which 1.0 μL of Endo F2 was directly added to 100 μL of the drug substance for enzyme digestion at 37 ℃. Through HRMS, the data were deconvoluted to obtain the accurate mass of the drug substance. The results showed that when the digestion time of Endo F2 was 5 min, the glycans in the Fab segment could be completely removed, whereas those in the Fc segment were not affected. Rapid enzyme cutting of the Fab glycans was realized; simultaneously, it was concluded that this method was also very specific for the removal of Fab glycans. In the second step, an accurate ratio analysis test was performed on Fab glycans excised from CHO-cetuximab. The released Fab glycans were precipitated with ice ethanol, the supernatant was centrifuged and spin-dried, and then labeled with para-aminobenzyl (2-AB). 2-AB labeling could make glycans have fluorescent detectable signals, and after reconstitution in 70% acetonitrile aqueous solution, was detected by UPLC coupled with a fluorescence detector (FLR). Good chromatographic peak separation was obtained using a hydrophilic interaction chromatography (HILIC) column. Thus, the test enabled stable glycan ratio analysis. The molecular weight results for three independent Endo F2 digestion cycles for 5 min showed that the masses after digestion were similar; subsequently, glycan ratio analysis was performed based on HILIC. The results of three independent glycan ratio analysis experiments were also similar, indicating that the rapid enzyme digestion of Endo F2 followed by glycan ratio analysis after 5 min of digestion yielded good stability and reliability. Data obtained by measuring the samples produced using two different processes employed by our company showed that there were distinct differences in the glycan profiles of the two processes, especially in terms of the sialic acid glycoforms. These results prove that the method developed in this study can accurately analyze the ratio of glycans. Monitoring the antibody production process is important and meaningful for the evaluation of the process." @default.
• W4210383784 created "2022-02-08" @default.
• W4210383784 creator A5007132849 @default.
• W4210383784 creator A5007191488 @default.
• W4210383784 creator A5043282426 @default.
• W4210383784 creator A5058458930 @default.
• W4210383784 creator A5064714350 @default.
• W4210383784 creator A5082205033 @default.
• W4210383784 creator A5088859569 @default.
• W4210383784 date "2022-02-01" @default.
• W4210383784 modified "2023-10-14" @default.
• W4210383784 title "Analysis of glycan ratio of Chinese hamster ovary cell-cetuximab antigen-binding segment via rapid enzyme digestion with endo-&lt;italic&gt;&beta;&lt;/italic&gt;-&lt;italic&gt;N&lt;/italic&gt;-acetylglucosaminidase F" @default.
• W4210383784 cites W2067367025 @default.
• W4210383784 cites W2145627626 @default.
• W4210383784 cites W2160241845 @default.
• W4210383784 cites W230513978 @default.
• W4210383784 cites W2330451514 @default.
• W4210383784 cites W2341711326 @default.
• W4210383784 cites W2437541722 @default.
• W4210383784 cites W2569867428 @default.
• W4210383784 cites W2597413779 @default.
• W4210383784 cites W2778963731 @default.
• W4210383784 cites W2789682399 @default.
• W4210383784 cites W2791987218 @default.
• W4210383784 cites W2901207337 @default.
• W4210383784 cites W2923750883 @default.
• W4210383784 cites W2991536560 @default.
• W4210383784 cites W2994564850 @default.
• W4210383784 cites W3002909994 @default.
• W4210383784 cites W3006773093 @default.
• W4210383784 doi "https://doi.org/10.3724/sp.j.1123.2021.05008" @default.
• W4210383784 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35080164" @default.
• W4210383784 hasPublicationYear "2022" @default.
• W4210383784 type Work @default.
• W4210383784 citedByCount "0" @default.
• W4210383784 crossrefType "journal-article" @default.
• W4210383784 hasAuthorship W4210383784A5007132849 @default.
• W4210383784 hasAuthorship W4210383784A5007191488 @default.
• W4210383784 hasAuthorship W4210383784A5043282426 @default.
• W4210383784 hasAuthorship W4210383784A5058458930 @default.
• W4210383784 hasAuthorship W4210383784A5064714350 @default.
• W4210383784 hasAuthorship W4210383784A5082205033 @default.
• W4210383784 hasAuthorship W4210383784A5088859569 @default.
• W4210383784 hasBestOaLocation W42103837841 @default.
• W4210383784 hasConcept C108625454 @default.
• W4210383784 hasConcept C153911025 @default.
• W4210383784 hasConcept C159654299 @default.
• W4210383784 hasConcept C170493617 @default.
• W4210383784 hasConcept C175656101 @default.
• W4210383784 hasConcept C185592680 @default.
• W4210383784 hasConcept C203014093 @default.
• W4210383784 hasConcept C206212055 @default.
• W4210383784 hasConcept C2777313579 @default.
• W4210383784 hasConcept C2779998722 @default.
• W4210383784 hasConcept C542903549 @default.
• W4210383784 hasConcept C55493867 @default.
• W4210383784 hasConcept C86803240 @default.
• W4210383784 hasConceptScore W4210383784C108625454 @default.
• W4210383784 hasConceptScore W4210383784C153911025 @default.
• W4210383784 hasConceptScore W4210383784C159654299 @default.
• W4210383784 hasConceptScore W4210383784C170493617 @default.
• W4210383784 hasConceptScore W4210383784C175656101 @default.
• W4210383784 hasConceptScore W4210383784C185592680 @default.
• W4210383784 hasConceptScore W4210383784C203014093 @default.
• W4210383784 hasConceptScore W4210383784C206212055 @default.
• W4210383784 hasConceptScore W4210383784C2777313579 @default.
• W4210383784 hasConceptScore W4210383784C2779998722 @default.
• W4210383784 hasConceptScore W4210383784C542903549 @default.
• W4210383784 hasConceptScore W4210383784C55493867 @default.
• W4210383784 hasConceptScore W4210383784C86803240 @default.
• W4210383784 hasIssue "2" @default.
• W4210383784 hasLocation W42103837841 @default.
• W4210383784 hasLocation W42103837842 @default.
• W4210383784 hasLocation W42103837843 @default.
• W4210383784 hasOpenAccess W4210383784 @default.
• W4210383784 hasPrimaryLocation W42103837841 @default.
• W4210383784 hasRelatedWork W158779233 @default.
• W4210383784 hasRelatedWork W2039321593 @default.
• W4210383784 hasRelatedWork W2050727659 @default.
• W4210383784 hasRelatedWork W2149603938 @default.
• W4210383784 hasRelatedWork W2159423922 @default.
• W4210383784 hasRelatedWork W2612797151 @default.
• W4210383784 hasRelatedWork W2613429086 @default.
• W4210383784 hasRelatedWork W2792245399 @default.
• W4210383784 hasRelatedWork W4212993996 @default.
• W4210383784 hasRelatedWork W4377939783 @default.
• W4210383784 hasVolume "40" @default.
• W4210383784 isParatext "false" @default.
• W4210383784 isRetracted "false" @default.
• W4210383784 workType "article" @default.